CGC
Price
$1.46
Change
+$0.08 (+5.80%)
Updated
Sep 5 closing price
Capitalization
456.87M
62 days until earnings call
NBIX
Price
$144.10
Change
+$3.70 (+2.64%)
Updated
Sep 5 closing price
Capitalization
14.29B
59 days until earnings call
Interact to see
Advertisement

CGC vs NBIX

Header iconCGC vs NBIX Comparison
Open Charts CGC vs NBIXBanner chart's image
Canopy Growth
Price$1.46
Change+$0.08 (+5.80%)
Volume$19.09M
Capitalization456.87M
Neurocrine Biosciences
Price$144.10
Change+$3.70 (+2.64%)
Volume$1.23M
Capitalization14.29B
CGC vs NBIX Comparison Chart in %
Loading...
CGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NBIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGC vs. NBIX commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGC is a Hold and NBIX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CGC: $1.46 vs. NBIX: $144.10)
Brand notoriety: CGC: Notable vs. NBIX: Not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CGC: 97% vs. NBIX: 137%
Market capitalization -- CGC: $456.87M vs. NBIX: $14.29B
CGC [@Pharmaceuticals: Generic] is valued at $456.87M. NBIX’s [@Pharmaceuticals: Generic] market capitalization is $14.29B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGC’s FA Score shows that 0 FA rating(s) are green whileNBIX’s FA Score has 1 green FA rating(s).

  • CGC’s FA Score: 0 green, 5 red.
  • NBIX’s FA Score: 1 green, 4 red.
According to our system of comparison, NBIX is a better buy in the long-term than CGC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGC’s TA Score shows that 5 TA indicator(s) are bullish while NBIX’s TA Score has 5 bullish TA indicator(s).

  • CGC’s TA Score: 5 bullish, 5 bearish.
  • NBIX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, NBIX is a better buy in the short-term than CGC.

Price Growth

CGC (@Pharmaceuticals: Generic) experienced а -18.89% price change this week, while NBIX (@Pharmaceuticals: Generic) price change was +3.22% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.08%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +86.48%.

Reported Earning Dates

CGC is expected to report earnings on Nov 07, 2025.

NBIX is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NBIX($14.3B) has a higher market cap than CGC($457M). NBIX YTD gains are higher at: 5.568 vs. CGC (-46.715). NBIX has higher annual earnings (EBITDA): 557M vs. CGC (-410.31M). NBIX has more cash in the bank: 976M vs. CGC (144M). CGC has less debt than NBIX: CGC (328M) vs NBIX (439M). NBIX has higher revenues than CGC: NBIX (2.51B) vs CGC (275M).
CGCNBIXCGC / NBIX
Capitalization457M14.3B3%
EBITDA-410.31M557M-74%
Gain YTD-46.7155.568-839%
P/E RatioN/A42.63-
Revenue275M2.51B11%
Total Cash144M976M15%
Total Debt328M439M75%
FUNDAMENTALS RATINGS
CGC vs NBIX: Fundamental Ratings
CGC
NBIX
OUTLOOK RATING
1..100
1317
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
76
Overvalued
PROFIT vs RISK RATING
1..100
10068
SMR RATING
1..100
9959
PRICE GROWTH RATING
1..100
5646
P/E GROWTH RATING
1..100
10032
SEASONALITY SCORE
1..100
350

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NBIX's Valuation (76) in the Biotechnology industry is in the same range as CGC (92) in the Agricultural Commodities Or Milling industry. This means that NBIX’s stock grew similarly to CGC’s over the last 12 months.

NBIX's Profit vs Risk Rating (68) in the Biotechnology industry is in the same range as CGC (100) in the Agricultural Commodities Or Milling industry. This means that NBIX’s stock grew similarly to CGC’s over the last 12 months.

NBIX's SMR Rating (59) in the Biotechnology industry is somewhat better than the same rating for CGC (99) in the Agricultural Commodities Or Milling industry. This means that NBIX’s stock grew somewhat faster than CGC’s over the last 12 months.

NBIX's Price Growth Rating (46) in the Biotechnology industry is in the same range as CGC (56) in the Agricultural Commodities Or Milling industry. This means that NBIX’s stock grew similarly to CGC’s over the last 12 months.

NBIX's P/E Growth Rating (32) in the Biotechnology industry is significantly better than the same rating for CGC (100) in the Agricultural Commodities Or Milling industry. This means that NBIX’s stock grew significantly faster than CGC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CGCNBIX
RSI
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
53%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
54%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
70%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
72%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
71%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
72%
Advances
ODDS (%)
Bullish Trend 10 days ago
80%
Bullish Trend 1 day ago
71%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 27 days ago
59%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
64%
Aroon
ODDS (%)
Bullish Trend 1 day ago
77%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NBIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
THOAX45.860.13
+0.28%
Thornburg Global Opportunities A
FACPX44.44N/A
N/A
Fidelity Advisor Consumer Discret M
VCAAX12.53N/A
N/A
VALIC Company I Asset Allocation
COVUX13.65N/A
N/A
Columbia Overseas Value R
LOAGX16.34N/A
N/A
Lord Abbett International Growth F3

CGC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGC has been loosely correlated with ACB. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if CGC jumps, then ACB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGC
1D Price
Change %
CGC100%
+5.80%
ACB - CGC
66%
Loosely correlated
+1.66%
OGI - CGC
62%
Loosely correlated
+2.48%
TLRY - CGC
61%
Loosely correlated
+3.48%
CRON - CGC
57%
Loosely correlated
N/A
NBIX - CGC
31%
Poorly correlated
+2.64%
More